7th Annual Publication and Clinical Trial Transparency
Date: June 20-21, 2018 Location: Amsterdam, The Netherlands In its 7th year, CBI’s Publication and Clinical Trial Transparency creates a bridge…
Speeding Drug Development with Clinical Trials in a Dish
The average time to bring a new drug to market is 12 years—assuming it makes it through the rigorous regulatory…
NCI-MATCH precision medicine clinical trial releases new findings
The National Cancer Institute’s Molecular Analysis for Therapy Choice (NCI-MATCH) trial, the largest precision medicine trial of its kind, has…
New England Journal of Medicine publishes pivotal cemiplimab trials showing positive results in advanced cutaneous squamous cell carcinoma
Patients treated with cemiplimab experienced robust anti-tumor effects Data also presented today at the 2018 ASCO Annual Meeting Cemiplimab…
Phase II Clinical Trials of DCVAC Show Significant Benefit for Patients with Ovarian and Lung Cancer
SOTIO, a biotechnology company owned by the PPF Group, presented results from its Phase II clinical trials evaluating DCVAC, an…
ASCO 2018: CarThera presents promising preliminary efficacy data for treating recurrent glioblastoma
Preliminary data from the first clinical trial of the company’s intracranial ultrasound implant, SonoCloud®, show a good safety profile and…
Novo’s oral semaglutide outperforms Jardiance in late-stage study
Danish drugmaker Novo Nordisk said Tuesday its PIONEER 2 study testing oral semaglutide in patients with type 2 diabetes met…
AstraZeneca won’t submit lung drug for COPD after 2nd study miss
AstraZeneca no longer plans to seek approval of its new respiratory biologic Fasenra in chronic obstructive pulmonary disease (COPD) after the…
Madrigal scores in mid-stage NASH study
Madrigal Pharmaceuticals on Thursday reported highly anticipated results for its Phase 2 non-alcoholic steatohepatitis (NASH) drug MGL-3196, unveiling positive data…